Medistat has been working with biotechnology and pharmaceutical companies for over 25 years, providing a wide variety of professional statistical and data management services for medical research
(pharmaceutical and medical devices).
Medistat is involved in development process from pre-clinical phase through phase I, phase II, phase III and phase IV (post-marketing surveillance-PMS).
Dr. Tami Wolf Goldberg
Clinical Data Team Lead
In 2013, Tami became a part of Medistat, bringing with her a PhD in Medical Science from Tel-Aviv University. Her expertise lies in CRF and clinical database design, medical coding, medical monitoring, and medical writing. Currently serving as the clinical data team lead, Tami plays a pivotal role in managing and guiding the clinical data team at Medistat.
Data management Team Lead
In 2015, David joined Medistat, bringing his expertise with an M.Sc. in Biostatistics from Tel-Aviv University. Serving as the architect of the Drug Inventory Management System and leading the Data Management team, David plays a pivotal role in both technical development and team leadership at Medistat.
Dr. Gil Harari
CEO & Founder
Gil founded Medistat in 1995.
He graduated with a PhD in Epidemiology and bio-statistics from Haifa University.
Gil specializes in bio-statistics and data mining. He is also the author of the book "Statistics in Medicine".
Biostatistic Team Lead
In 2019, Alex Perez joined Medistat, bringing her expertise with an MSc in Physics and Statistics from Tel Aviv University. Serving as the Biostatistics Team Lead, Alex plays a crucial role in both strategic development and team leadership at Medistat, contributing significantly to the company's success.